AAA1 involves an inherited genetic predisposition to abdominal aortic aneurysm. The inheritance patterns recorded for this entity span autosomal dominant, autosomal recessive, and multifactorial modes; specific causative gene variants are not identified in this data set. Prevalence and population frequency data are not available in this packet.

Diagnosis of AAA1 involves identification of abdominal aortic aneurysm in individuals with a family history consistent with hereditary predisposition. Imaging of the abdominal aorta — typically by ultrasound, computed tomography, or magnetic resonance imaging — establishes the anatomic diagnosis. Specific molecular genetic diagnostic criteria for AAA1 are not defined in this data set.

No FDA-approved pharmacological treatments specifically for AAA1 are recorded in this data set, and no orphan drug designations are listed for this condition. Clinical management of aortic aneurysm as a structural entity encompasses endovascular and open surgical repair strategies; active clinical investigation includes evaluation of various endovascular graft systems and procedural approaches in the broader aortic aneurysm population.

Detailed prognostic data specific to AAA1 as a hereditary entity are not available in this data set.

Active clinical investigation in the aortic aneurysm field encompasses endovascular device post-approval studies, comparative trials of graft systems, surgical technique research, and pain management studies in aneurysm repair. Clinical trials are ongoing in the United States, Europe, and Asia, with participation from academic medical centers and industry sponsors. Research specific to the hereditary or familial forms of abdominal aortic aneurysm is not separately characterized within the active trial records in this data set.